Comparison of Different Anti-<b><i>Demodex</i></b> Strategies: A Systematic Review and Meta-Analysis

蠕形螨 伊维菌素 医学 氯菊酯 皮肤病科 甲硝唑 酒渣鼻 痤疮 农学 兽医学 植物 生物 微生物学 杀虫剂 抗生素
作者
Jiahua Li,Erdong Wei,Amin Reisinger,Lars E. French,Benjamin M. Clanner‐Engelshofen,Markus Reinholz
出处
期刊:Dermatology [S. Karger AG]
卷期号:239 (1): 12-31 被引量:4
标识
DOI:10.1159/000526296
摘要

Background: Demodex mites are related to some inflammatory diseases such as rosacea and blepharitis and could be harmful in patients with immunodeficiency or immunosuppression, especially notable in patients using biologic like dupilumab. In order to have an objective observation of different anti-Demodex strategies, we conducted this study, based on interventional clinical evidence with quantified Demodex mite data. Methods: We used the PubMed, Embase, ClinicalTrials.gov, Medline, and International Clinical Trials Registry Platform (ICTRP) as databases. To assess the risk of bias, the RoB2 and ROBINS-I tools were used. The certainty of evidence was assessed following the GRADE guideline. Furthermore, the effect sizes (ESs) of different strategies were compared in different time periods (0–1, 1–2, 2–3, >3 months), as well as Demodex decrease rates. Results: 1,618 studies were identified in the databases, with 21 of which included in the final quantitative synthesis. Interventions in these studies included ivermectin, tea tree oil (TTO), permethrin, crotamiton, metronidazole, light therapies, combined therapies, and other therapies. During 0–1 month, the ES varied from 0.07 (cleanser) to 1.95 (systemic ivermectin-metronidazole). During 1–2 months, the ES varied from 0.88 (topical permethrin) to 4.40 (topical ivermectin). During 2–3 months, the ES varied from 0.79 (topical permethrin) to 8.37 (topical ivermectin). During the time of 3 months, the ES varied from 0.59 (topical permethrin) to 2.25 (intense pulsed light [IPL]). In terms of Demodex decrease rates, topical ivermectin, TTO, permethrin, IPL, and baby shampoo had achieved a nearly 100% decrease. The reported adverse events were mostly mild, without severe adverse events reported in any of the studies. Conclusions: We found ivermectin (topical and systemic), ivermectin-metronidazole (topical), and TTO (topical) are promising anti-Demodex interventions. In addition to traditional pharmacotherapy, light therapies, especially IPL and skin cleansing, could also be considered as effective methods to control Demodex mite infestation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
白桃发布了新的文献求助10
4秒前
酷波er应助山月为衾采纳,获得10
5秒前
木木发布了新的文献求助10
6秒前
linyalala完成签到,获得积分20
8秒前
dyj发布了新的文献求助10
8秒前
9秒前
凌云完成签到,获得积分10
9秒前
冰可乐完成签到 ,获得积分10
10秒前
Andy完成签到,获得积分10
10秒前
领导范儿应助枝江泥头车采纳,获得10
10秒前
乐于曰发布了新的文献求助10
12秒前
12秒前
brightjoe完成签到 ,获得积分0
13秒前
13秒前
小钱发布了新的文献求助20
16秒前
li完成签到,获得积分10
16秒前
Setsail24k完成签到,获得积分10
16秒前
16秒前
Singularity应助Alvin采纳,获得10
17秒前
木子Q发布了新的文献求助10
17秒前
难过初柔发布了新的文献求助10
17秒前
18秒前
mengloo完成签到,获得积分10
18秒前
枝江泥头车完成签到,获得积分10
20秒前
echoMe完成签到 ,获得积分10
22秒前
千祜完成签到,获得积分20
22秒前
22秒前
柯忻完成签到,获得积分10
25秒前
CodeCraft应助孙英苹采纳,获得100
25秒前
Lett发布了新的文献求助100
25秒前
25秒前
聪明邪欢完成签到,获得积分10
26秒前
26秒前
小怪发布了新的文献求助10
26秒前
27秒前
Mona完成签到,获得积分10
28秒前
个性的紫菜应助鲤鱼谷波采纳,获得20
29秒前
山月为衾发布了新的文献求助10
32秒前
可爱迪应助朱问安采纳,获得10
33秒前
高分求助中
请在求助之前详细阅读求助说明 20000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
The Three Stars Each: The Astrolabes and Related Texts 500
Sphäroguß als Werkstoff für Behälter zur Beförderung, Zwischen- und Endlagerung radioaktiver Stoffe - Untersuchung zu alternativen Eignungsnachweisen: Zusammenfassender Abschlußbericht 500
Revolutions 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2461009
求助须知:如何正确求助?哪些是违规求助? 2130705
关于积分的说明 5428758
捐赠科研通 1857832
什么是DOI,文献DOI怎么找? 923952
版权声明 562463
科研通“疑难数据库(出版商)”最低求助积分说明 494280